Elevated troponin levels in patients with atrial tachyarrhythmias
Zach Rozenbaum1, Orly Sapir1, Philippe Taieb1
1Department of Cardiology, Tel Aviv Medical Center and Sackler School of Medicine.
Insights
Elevated troponin levels are not reliable indicators of obstructive coronary artery disease (CAD) in patients with atrial tachyarrhythmias. Risk stratification should consider troponin levels, diabetes, and prior ischemic heart disease.
Area of Science:
- Cardiology
- Internal Medicine
- Diagnostic Imaging
Background:
- Elevated troponin levels are commonly observed in patients with atrial tachyarrhythmias, but their significance in diagnosing obstructive coronary artery disease (CAD) remains unclear.
- Atrial tachyarrhythmias can independently increase troponin levels, potentially confounding the diagnosis of acute myocardial infarction.
Purpose of the Study:
- To evaluate the discriminative ability of troponin in identifying obstructive CAD among patients presenting with atrial tachyarrhythmias.
- To compare the prevalence of obstructive CAD in patients with and without atrial tachyarrhythmias who have elevated troponin levels.
Main Methods:
- Retrospective analysis of 318 patients undergoing coronary angiography.
- Comparison between 159 patients with atrial tachyarrhythmias and elevated troponin and 159 matched controls without arrhythmias.
- Inclusion criteria: suspected non-ST elevation myocardial infarction and elevated serum troponin levels.
Main Results:
- Obstructive CAD was significantly less prevalent in patients with atrial tachyarrhythmias (39%) compared to controls (85.5%) (P < 0.001).
- Multivariable analysis identified diabetes mellitus (OR 2.7), prior ischemic heart disease (OR 4.48), and troponin level (OR 3.18 per 1000 ng/L increment) as predictors of obstructive CAD in patients with atrial tachyarrhythmias.
Conclusions:
- Elevated troponin is not a reliable marker for obstructive CAD in patients with atrial tachyarrhythmias.
- Risk stratification for obstructive CAD in this population should incorporate the degree of troponin elevation, presence of diabetes mellitus, and history of ischemic heart disease.
Objective:
Data regarding the significance of elevated troponin in the setting of atrial tachyarrhythmia remain inconclusive. In the present study, we aimed to explore the discriminative ability of troponin for obstructive coronary artery disease (CAD) among patients with atrial tachyarrhythmias.
Methods:
We retrospectively identified patients with atrial tachyarrhythmias and elevated serum troponin levels, who underwent invasive coronary angiography during the same admission. The prevalence of obstructive CAD among these patients was compared to that of historically matched patients who underwent coronary angiography due to suspected non-ST elevation myocardial infarction and had no arrhythmias.
Results:
Overall 318 patients with suspected non-ST elevation myocardial infarction were analyzed (n = 159 with atrial tachyarrhythmias and n = 159 without arrhythmias). Obstructive CAD was detected in 39% of patients with an arrhythmia compared to 85.5% in the control group (P < 0.001). A multivariable analysis demonstrated that parameters associated with obstructive CAD among patient with atrial tachyarrhythmias and elevated troponin were diabetes mellitus [odds ratio (OR) 2.7, 95% confidence interval (CI) 1.23-5.91, P = 0.013], prior ischemic heart disease (OR 4.48, 95% CI 1.93-10.4, P < 0.001) and troponin level (OR 3.18 for every 1000 ng/L increment, 95% CI 1.85-5.48, P < 0.001).
Conclusions:
Elevated troponin is not a reliable indicator for the presence of underlying obstructive CAD among patients who present with atrial tachyarrhythmias. Risk stratification of these patients should rely on the degree of troponin elevation, and the presence of diabetes mellitus and prior ischemic heart disease.
More Related Videos
09:23Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Dysrhythmias II: Classification of Tachyarrhythmias
Dysrhythmias V: Evaluating Dysrhythmias
